Atrial fibrillation (AF) is the most common arrhythmia. It is expected to affect 6-12 million Americans by 2050. AF is a major public health burden, associated with a 5-fold increased stroke risk, doubling in dementia risk, tripling in heart failur risk and nearly 2-fold increase in mortality. The estimated excess cost of health care due to AF is nearly $26 billion annually. AF is known to be heritable, and in recent years, 3 genetic loci fo AF have been identified through genome-wide association studies. More recently, we completed a large meta-analysis of genome-wide studies and identified 6 novel loci for AF. We will build upon our prior work using a multidisciplinary approach that integrates targeted sequencing of all 9 AF GWAS loci, robust replication in the CHARGE AF Consortium, and model system based functional analyses. We will take advantage of two well- characterized cohorts with early-onset AF from the Framingham Heart Study and Massachusetts General Hospital. Specifically, we propose to: 1) Identify potentially causative genetic variants at the 9 published GWAS loci by analyzing extant targeted sequencing data of the top 5 loci for AF generated by the NIH Resequencing and Genotyping Service in 480 individuals with early-onset AF and 480 referents and by performing new targeted sequencing of 4 additional AF loci in the same subjects. 2) Replicate the top 400 AF variants with MAF>0.5% identified in our targeted sequencing projects in 5,776 independent AF cases and 9,229 referents, and replicate the rare and singleton SNPs (MAF<0.5%) in the top 3 genetic regions in 1,000 independent individuals with early-onset AF and 1,000 referents. 3) Functionally evaluate the newly identified genetic variants for AF by using cellular electrophysiology to characterize coding variation in ion channel and using a combination of zebra fish, mice, and cell-based assays to examine non-coding variants at the two most promising AF related loci. Our translational approach will facilitate a greater understanding of the molecular basis of this common and morbid arrhythmia. Identification of causative variants may enhance risk stratification, and will provide preventive and therapeutic targets for drug discovery in the broader scientific and pharmaceutical community.

Public Health Relevance

Despite affecting ~3 million Americans, relatively little is known about the underlying mechanisms that lead to atrial fibrillation (AF). The goal of this application is to perform sequencing of 9 genomic regions associated with AF in individuals with early-onset atrial fibrillation to find the causative genetic variants associated with this arrhythmia. Identifying the causal variants will lead to better risk stratification, improved treatment, and potentially prevention of AF.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Cardiovascular and Sleep Epidemiology Study Section (CASE)
Program Officer
Papanicolaou, George
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Mahida, Saagar; Mills, Robert W; Tucker, Nathan R et al. (2014) Overexpression of KCNN3 results in sudden cardiac death. Cardiovasc Res 101:326-34
Savio-Galimberti, Eleonora; Darbar, Dawood (2014) Atrial Fibrillation and SCN5A Variants. Card Electrophysiol Clin 6:741-748
Tucker, Nathan R; Ellinor, Patrick T (2014) Emerging directions in the genetics of atrial fibrillation. Circ Res 114:1469-82
Magnani, Jared W; Brody, Jennifer A; Prins, Bram P et al. (2014) Sequencing of SCN5A identifies rare and common variants associated with cardiac conduction: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. Circ Cardiovasc Genet 7:365-73
Chugh, Sumeet S; Havmoeller, Rasmus; Narayanan, Kumar et al. (2014) Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 129:837-47
Lin, Honghuang; Dolmatova, Elena V; Morley, Michael P et al. (2014) Gene expression and genetic variation in human atria. Heart Rhythm 11:266-71
Frost, Lars; Benjamin, Emelia J; Fenger-Grøn, Morten et al. (2014) Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish cohort study. Obesity (Silver Spring) 22:1546-52
Lin, Honghuang; Sinner, Moritz F; Brody, Jennifer A et al. (2014) Targeted sequencing in candidate genes for atrial fibrillation: the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Targeted Sequencing Study. Heart Rhythm 11:452-7
Sinner, Moritz F; Tucker, Nathan R; Lunetta, Kathryn L et al. (2014) Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation 130:1225-35
Ho, Jennifer E; Yin, Xiaoyan; Levy, Daniel et al. (2014) Galectin 3 and incident atrial fibrillation in the community. Am Heart J 167:729-34.e1

Showing the most recent 10 out of 87 publications